california semaglutide ban update 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like and tirzepatide) are not banned entirely — but access is changing. The Novo Nordisk expands Wegovy access

This includes evaluating underlying factors such as PCOS, insulin resistance, prediabetes, or other metabolic conditions that can make weight loss more challenging

[9] [10] Infections or inflammatory conditions : Unexplained night sweats, particularly when accompanied by fever, fatigue, or unintentional weight loss beyond your intended deficit, may indicate an underlying infection (including tuberculosis in those with relevant risk factors) or, in rarer cases, a haematological condition

Mice treated with metformin showed the similar results to those from OA group in the rotarod test (Fig

It uses a gradual, steady approach and is the more established GLP-1 option